1 INDICATIONS AND USAGE Ranolazine extended-release tablets are indicated for the treatment of chronic angina. Ranolazine extended-release tablets may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ACE inhibitors, and angiotensin receptor blockers. Ranolazine extended-release tablets are an antianginal indicated for the treatment of chronic angina. ( 1 )
Westminster Pharmaceuticals, LLC
16 HOW SUPPLIED/STORAGE AND HANDLING
RANOLAZINE extended-release tablets are supplied as film-coated, oblong-shaped, extended-release tablets in the following strengths: 500 mg tablets are peach, with "423" on one side and "SG" on the other side 1000 mg tablets are pale yellow, with "424" on one side and "SG" on the other side
RANOLAZINE extended-release tablets 500 mg are available in: Bottle of 60 Tablets: NDC 69367-293-60
RANOLAZINE extended-release tablets 1000 mg are available in: Bottle of 60 Tablets: NDC 69367-294-60 Store at 25Â°C (77Â°F); with excursions permitted to 15Â°C to 30Â°C (59Â°F to 86Â°F). [See USP Controlled Room Temperature.]
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site